Cite
HARVARD Citation
Di Giusto, S. et al. (2023). BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment‐free remission: A study from the "GRUPPO TRIVENETO LMC". Cancer medicine. pp. 3180-3184. [Online].